IMPORTANCE While 1 in 10 older patients hospitalized with heart failure (HF) die within 30 days, end-of-life care for this population is not well described.
P atients with heart failure (HF) report a high symptom burden, and despite therapeutic advances, the median survival among Medicare beneficiaries hospitalized with HF is only 2.1 years.
1,2 Therefore, many patients with HF may benefit from palliative care and hospice. Hospice, a Medicare benefit, is a form of palliative care for patients with an expected survival of less than 6 months. While the number of patients with HF dying in hospice is increasing, patients with cardiovascular disease have been identified as having the greatest unmet need for palliative care. [3] [4] [5] Therefore, we used the American Heart Association Get With The Guidelines (GWTG)-HF hospital inpatient registry linked to Medicare claims data to assess trends, care patterns, and outcomes of patients with HF discharged to hospice.
Methods
The data for this analysis were obtained from the GWTG-HF registry linked to Medicare claims. The GWTG-HF program is a national registry that enrolls consecutive patients admitted to the hospital with worsening HF or if they develop HF symptoms during a hospitalization for which HF is the primary diagnosis at discharge. 6 All participating institutions secured institutional review board approval as necessary. Because data were used primarily at the local sites for quality improvement, a waiver of informed consent was granted under the common rule. Quintiles (Cambridge, Massachusetts) served as the registry coordinating center, and the Duke Clinical Research Institute (Durham, North Carolina) was the data analysis center. Institutional review board approval was granted to analyze the aggregate, deidentified data.
Patients
We included all 121 990 index HF hospitalizations in the GWTG-HF registry between January 1, 2005, and December 31, 2014, of patients 65 years and older linked with US Centers for Medicare and Medicaid inpatient claims eligible for Part A and B fee-for-service during the discharge month. 7 If a patient had multiple hospitalizations, the first HF hospitalization identified during the study period was used as the index HF hospitalization. Medicare files included all fee-forservice Medicare beneficiaries with follow-up through the end of December 2015. We excluded 8330 patients with missing discharge disposition, who died in-hospital, who transferred to another short-term hospital, who left against medical advice, and/or with missing socioeconomic information.
Patients were listed as being discharged to home hospice care (n = 2424) or to a medical hospice facility (n = 2164). We compared these patients with 4357 patients with advanced HF (ejection fraction ≤25% and any of the following: inpatient inotrope use, serum sodium level ≤130 mEq/L, blood urea nitrogen level ≥45 mg/dL [to convert to micromoles per liter, multiply by 0.357], systolic blood pressure ≤90 mm Hg, or comfort measures during hospitalization) not discharged to hospice and 113 045 other patients with HF in the GWTG-HF registry.
Outcomes
The primary outcomes of interest were all-cause mortality, allcause readmission, and a composite of mortality/readmission at 30 days, 6 months, and 1 year after index discharge. Allcause mortality was determined based on death dates in the Medicare denominator files, and readmissions were defined as any new nonelective inpatient claim (excluding the index hospitalization claim), transfers to or from another hospital, and admissions for rehabilitation.
Secondary outcomes/end points that we analyzed included demographic, biologic, hospital, and sociological factors, and we assessed if they were associated with discharge to hospice. We assessed the outcomes of patients admitted to the hospital by final disposition, eg, death, discharge to hospice, or discharge without hospice plan. Left ventricular assist device placement or heart transplantation was assessed by International Classification of Diseases, Ninth Revision and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision procedure codes. When assessing trends in hospice discharges, hospital characteristics were excluded given differences in hospital characteristics that enrolled earlier in the GWTG-HF registry. Symptom severity at discharge was assessed using review of patient clinical documentation at discharge.
Statistical Analysis
Patient demographic characteristics, medical history, admission data, and hospital characteristics were collected for patients with HF discharged to hospice, patients with advanced HF, and other patients with HF in the GWTG-HF registry. Proportions and medians with interquartile ranges (IQRs) are reported for categorical and continuous variables, respectively. The Pearson χ 2 test was used to compare binary or nominal categorical variables, and Kruskal-Wallis tests were used to compare continuous or ordinal categorical variables. Percent standardized differences (standardized differences × 100) were calculated. Cumulative incidences were described for all follow-up outcomes in all patient groups. Cumulative incidence for readmission outcomes accounted for the competing risk of mortality. Log-rank test was used to assess the difference in mortality. Gray test was used to assess differences in readmission outcomes. We examined the unadjusted and adjusted associations of follow-up outcomes with patient groups using Cox proportional hazards models on the subdistribution hazards. Fine and Gray methods account for the competing risks of deaths. Robust sandwich variance estimators were used in the model to account for correlation among patients from the same hospital. The following covariates were used for adjustment in this analysis: demographic characteristics (age, sex, and race/ ethnicity), medical history (anemia, ischemic etiology, cerebrovascular accident/transient ischemic attack, diabetes, hyperlipidemia, hypertension, chronic obstructive pulmonary disease or asthma, peripheral vascular disease, renal insufficiency, and smoking) examination and laboratory findings (left ventricular ejection fraction, heart rate, systolic blood pressure, body mass index, serum creatinine level, serum sodium level, and blood urea nitrogen level), hospital characteristics (geographic region, teaching status, number of beds, and rural location), and other factors (year and quarter of index admission, median home value, median household income, high school education, and college education). We repeated this analysis comparing patients discharged to home hospice vs a hospice facility. When identifying factors associated with higher risk of readmission in patients discharged to hospice, we reported hazard ratio (HR) estimates and P values for each covariate from the adjusted model on all-cause readmission. We used the Cochran-Armitage trend test to analyze trend in hospice rate in patients with HF by year.
Medical history missing was imputed to no. For all other covariates with missingness, multiple imputation with 25 imputed data sets was used. All P values were 2-tailed, and a P value less than .05 was considered statistically significant. All analyses were performed using SAS software version 9.4 (SAS Institute).
Results

Study Cohort
The initial population of patients hospitalized with HF who were discharged alive between January 1, 2005, and December 31, 2014, was 391 977 patients from 477 sites. Of these, 121 990 patients (31.1%) from 438 sites (91.8%) were included in the analysis (eFigure in the Supplement).
Baseline Characteristics
Overall Of the study cohort, 4588 (3.8%) were discharged to hospice, 4357 (3.6%) had advanced HF, and 113 045 (92.7%) were other patients with HF in the GWTG-HF registry ( Table 1) . Missing rates of key variables are provided in eTable 1 in the Supplement. Patients discharged to hospice were older, were more likely to be white, had higher education, and had worse HF severity than patients with advanced HF or other patients in the GWTG-HF registry. Patients discharged to hospice had a higher prevalence of atrial fibrillation, chronic obstructive pulmonary disease, cerebrovascular accident/transient ischemic attack, anemia, depression, and valvular heart disease and a lower prevalence of diabetes, hyperlipidemia, chronic dialysis use, and smoking than patients with advanced HF and other patients in the GWTG-HF registry. At discharge, patients in hospice were much more likely to have worse or unchanged symptoms compared with patients with advanced HF or other patients in the Overall, there were 6350 patients (5.2%) in our study cohort who received comfort measures only at any point during the hospitalization and survived to discharge, 3192 (50.3%) of whom were discharged to hospice. Most of the 4588 patients discharged to hospice received comfort measures (n = 3192 [69.6%]), followed by patients with advanced HF (n = 578 [13.3%]) and other patients in the GWTG-HF registry (n = 2580 [2.3%]). The median (IQR) length of stay for both patients discharged to hospice and patients with advanced HF was 6 (3-9) days and for other patients in the GWTG-HF registry was 4 (3-6) days. Patients discharged to hospice were much less likely to be discharged with prescriptions for HF and cardiovascular medications than other groups, although a substantial proportion were discharged with prescriptions for medications unlikely to provide them symptomatic benefit, such as aspirin (501 [38.8%]) and lipid-lowering therapies (328 [27.1%]) (eTable 2 in the Supplement).
Home Hospice vs Hospice Facility
Of patients discharged to hospice, 2424 (52.8%) were discharged to home hospice and 2164 (47.2%) were discharged to a hospice facility. Compared with patients discharged to home hospice, patients discharged to hospice facilities were more likely to be older (median [IQR] 
Trends and Hospital-Level Variation in Hospice Discharge Rate
The hospice discharge rate in our study population increased from 2.0% (109 of 5528) in 2005 to 4.9% (968 of 19 590) in 2014 (P value for trend < .001) (eTable 4 in the Supplement). Significant hospital-level variation in hospice discharge rate was noted. The median (IQR) hospice discharge rate among all sites was 3.0% (0.7%-5.5%) and among sites with at least 25 patients in the study population was 3.5% (2.0%-5.7%) ( Figure 1A) . After risk adjustment, the median (IQR) hospice discharge rate was 3.6% (3.2%-4.5%) ( Figure 1B ). Patients discharged to hospice were more likely to receive care in hospitals in the western and southern regions and less likely to be in the northeast region and in rural and teaching hospitals (Table 1) Figure 2B ). Patients discharged to hospice also had greater hazards of the composite outcome of all-cause mortality and allcause readmission in both adjusted and unadjusted analyses compared with patients with advanced HF and other patients in the GWTG-HF registry ( Figure 2C ). Lastly, patients discharged to home hospice had lower cumulative incidence and hazards of mortality, higher incidence and hazards of readmission, and lower incidence of the composite end point of allcause mortality and readmission compared with patients discharged to hospice facilities ( Figure 3 ) (eTable 10 in the Supplement).
Characteristics of Patients Readmitted From Hospice
Patients discharged to hospice who were readmitted (497 of 4588) compared with patients with advanced HF (2948 of 4357) and other patients in the GWTG-HF registry (73 804 of 113 045) 
Discussion
This study provides an overview of trends and patterns in hospice use for patients with HF in the United States. Only 4.9% of Medicare patients hospitalized with HF were discharged to hospice, and there was significant hospital-level variation in hospice discharge rates. More than one-third of patients were discharged to hospice with unchanged or worsening symptoms compared with only 1% to 2% of other patients in the GWTG-HF registry. The median survival time in hospice was only 11 days, and nearly one-quarter of patients discharged to hospice died less than 3 days of discharge. The median survival time of patients discharged to hospice facilities was even shorter at 5 days. Black race and younger age were the strongest predictors of readmission from hospice. These findings highlight significant areas for potential improvement in the quality of end-of-life care received by patients with HF. Our study confirms the poor overall survival of older adults discharged after an HF hospitalization. Abbreviations: HF, heart failure; HR, hazard ratio; NA, not applicable.
a Log-rank P value is shown for mortality and Gray P value is shown for other outcomes.
b The first P value has 3 df and tests if hazards of a given outcome is different in at least 1 pair of groups; other P values test whether hazards in given comparison groups are significantly different. The following covariates were used for adjustment in this analysis: demographic characteristics (age, sex, and race/ethnicity), medical history (anemia, ischemic etiology, cerebrovascular accident/transient ischemic attack, diabetes, hyperlipidemia, hypertension, chronic obstructive pulmonary disease or asthma, peripheral vascular disease, renal insufficiency, and smoking) examination and laboratory findings (left ventricular ejection fraction, heart rate, systolic blood pressure, body mass index, serum creatinine level, serum sodium level, and blood urea nitrogen level), hospital characteristics (geographic region, teaching status, number of beds, and rural location), and other factors (year and quarter of index admission, median home value, median household income, high school education, and college education). This might be one important reason why patients with heart disease continue to be grossly underrepresented in the hospiceenrolled population in the United States compared with patients with other diseases, such as cancer. 4 Therefore, early recognition of poor prognosis and palliative consultation could facilitate timely hospice referral. 17 In our study, 15% of patients survived more than 6 months, similar to rates for other diseases. 18, 19 However, about 1 in 10 patients in our study discharged to hospice survived for more than 1 year. It would also be useful to develop tools to predict patients who experience such long survival in hospice. Disenrollment from hospice is another potential metric of suboptimal end-of-life care. 20 Younger age and black race were the most significant predictors of hospital readmission after adjustment for other variables. Disparities in palliative care use have been extensively noted among black patients. 21 Furthermore, we found significant variation between hospitals in hospice discharge rate in our study. This finding warrants further investigation to identify factors driving high and low hospice discharge rates in hospitals.
Our study found important differences in patients discharged to home hospice vs those discharged to hospice facilities. Patients discharged to hospice facilities had much shorter survival than patients discharged to home hospice. This suggests that patients discharged to hospice facilities might be sicker. However, patients discharged to hospice facilities had higher income than patients discharged home. Hospice facilities have additional out-of-pocket costs, which might restrict access.
Limitations
Our study has several limitations. We only looked at index hospitalizations to simplify our look at subsequent outcomes, including readmission. Given the observational nature of this study, we cannot make inferences regarding causality when examining outcomes. The GWTG-HF registry is dependent on voluntary participation; thus, there is the potential for selection biases. However, Medicare beneficiaries in the registry have been shown in prior studies to be representative of the overall US Medicare population.
22
Finally, 13% of patients with advanced HF and 2% of other patients with HF received comfort measures only during the hospitalization. However, the aim of this study was to better define patterns of hospice use at the end of life for patients with HF. Lastly, GWTG did not gather information about type of hospice care, categorized into routine home care, continuous home care (which can also be provided in a facility), general inpatient care, and inpatient respite care.
Conclusions
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